FI107233B - Menetelmä farmaseuttisen rokotekoostumuksen valmistamiseksi Neisseria meningitidis-infektioita vastaan - Google Patents

Menetelmä farmaseuttisen rokotekoostumuksen valmistamiseksi Neisseria meningitidis-infektioita vastaan Download PDF

Info

Publication number
FI107233B
FI107233B FI932491A FI932491A FI107233B FI 107233 B FI107233 B FI 107233B FI 932491 A FI932491 A FI 932491A FI 932491 A FI932491 A FI 932491A FI 107233 B FI107233 B FI 107233B
Authority
FI
Finland
Prior art keywords
gly
molecular weight
subunit
ser
lys
Prior art date
Application number
FI932491A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI932491A (fi
FI932491A0 (fi
Inventor
Marie-Jose Quentin-Millet
Original Assignee
Pasteur Merieux Serums Vacc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Merieux Serums Vacc filed Critical Pasteur Merieux Serums Vacc
Publication of FI932491A publication Critical patent/FI932491A/fi
Publication of FI932491A0 publication Critical patent/FI932491A0/fi
Application granted granted Critical
Publication of FI107233B publication Critical patent/FI107233B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/871—Neisseria

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FI932491A 1991-10-03 1993-06-01 Menetelmä farmaseuttisen rokotekoostumuksen valmistamiseksi Neisseria meningitidis-infektioita vastaan FI107233B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR9112177 1991-10-03
FR9112177A FR2682041B1 (fr) 1991-10-03 1991-10-03 Vaccin contre les infections a neisseria meningitidis.
PCT/FR1992/000905 WO1993006861A1 (fr) 1991-10-03 1992-09-29 VACCIN CONTRE LES INFECTIONS A $i(NEISSERIA MENINGITIDIS)
FR9200905 1992-09-29

Publications (3)

Publication Number Publication Date
FI932491A FI932491A (fi) 1993-06-01
FI932491A0 FI932491A0 (fi) 1993-06-01
FI107233B true FI107233B (fi) 2001-06-29

Family

ID=9417549

Family Applications (1)

Application Number Title Priority Date Filing Date
FI932491A FI107233B (fi) 1991-10-03 1993-06-01 Menetelmä farmaseuttisen rokotekoostumuksen valmistamiseksi Neisseria meningitidis-infektioita vastaan

Country Status (14)

Country Link
US (1) US5618541A (hu)
EP (1) EP0560968B1 (hu)
JP (1) JPH06503365A (hu)
AT (1) ATE140626T1 (hu)
AU (1) AU662176B2 (hu)
CA (1) CA2097056A1 (hu)
DE (1) DE69212459T2 (hu)
DK (1) DK0560968T3 (hu)
ES (1) ES2090696T3 (hu)
FI (1) FI107233B (hu)
FR (1) FR2682041B1 (hu)
HU (1) HU219673B (hu)
NO (1) NO306538B1 (hu)
WO (1) WO1993006861A1 (hu)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2682114B1 (fr) * 1991-10-03 1996-02-23 Pasteur Merieux Serums Vacc Vaccin de sous-unite contre les infections a neisseria meningitidis et sous-unites correspondantes a l'etat purifie.
FR2692592B1 (fr) * 1992-06-19 1995-03-31 Pasteur Merieux Serums Vacc Fragments d'ADN codant pour les sous-unités du récepteur de la transferrine de Neisseria meningitidis et procédés les exprimant.
AU705998B2 (en) * 1993-11-08 1999-06-03 Connaught Laboratories Limited Haemophilus transferrin receptor genes
FR2720408B1 (fr) * 1994-05-31 1996-08-14 Pasteur Merieux Serums Vacc Fragments Tbp2 de Neisseria meningitidis.
FR2739624B1 (fr) * 1995-10-10 1997-12-05 Pasteur Merieux Serums Vacc Nouvelle sous-unite tbp2 de neisseria meningitidis
US6290970B1 (en) * 1995-10-11 2001-09-18 Aventis Pasteur Limited Transferrin receptor protein of Moraxella
US6087036A (en) 1997-07-25 2000-07-11 3M Innovative Properties Company Thermal management system and method for a solid-state energy storing device
FR2767060B1 (fr) * 1997-08-07 2000-02-11 Pasteur Merieux Serums Vacc Vaccin meningocoque comportant la valence de souche bz83
GB9726398D0 (en) 1997-12-12 1998-02-11 Isis Innovation Polypeptide and coding sequences
GB9808866D0 (en) * 1998-04-24 1998-06-24 Smithkline Beecham Biolog Novel compounds
GB9810276D0 (en) * 1998-05-13 1998-07-15 Smithkline Beecham Biolog Novel compounds
FR2785293B1 (fr) * 1998-10-30 2002-07-05 Pasteur Merieux Serums Vacc Acides nucleiques et polypeptides specifiques des souches pathogenes du genre neisseria
GB9823978D0 (en) * 1998-11-02 1998-12-30 Microbiological Res Authority Multicomponent meningococcal vaccine
US10967045B2 (en) 1998-11-02 2021-04-06 Secretary of State for Health and Social Care Multicomponent meningococcal vaccine
WO2004015099A2 (en) 2002-08-02 2004-02-19 Glaxosmithkline Biologicals Sa Vaccine composition comprising lipooligosaccharide with reduced phase variability
DK2395073T3 (en) 2002-11-01 2017-10-23 Glaxosmithkline Biologicals Sa Process for drying.
WO2005032584A2 (en) 2003-10-02 2005-04-14 Glaxosmithkline Biologicals S.A. Pertussis antigens and use thereof in vaccination
RU2378010C2 (ru) 2003-10-02 2010-01-10 Новартис Вэксинес Энд Дайэгностикс С.Р.Л. Жидкие вакцины для множественных серогрупп менингококков
GB0505996D0 (en) 2005-03-23 2005-04-27 Glaxosmithkline Biolog Sa Fermentation process
JP5275983B2 (ja) 2006-06-12 2013-08-28 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム ワクチン
GB0700562D0 (en) 2007-01-11 2007-02-21 Novartis Vaccines & Diagnostic Modified Saccharides
JP2013521770A (ja) 2010-03-10 2013-06-13 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム ワクチン組成物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4681761A (en) * 1985-10-24 1987-07-21 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University Major iron-regulated protein of Neisseria gonorrhoeae and its use as vaccine
US5292869A (en) * 1989-04-27 1994-03-08 The Board Of Governors Of The University Method for isolating and purifying transferrin and lactoferrin receptor proteins from bacteria and the preparation of vaccines containing the same

Also Published As

Publication number Publication date
FR2682041B1 (fr) 1994-01-14
DE69212459T2 (de) 1996-12-05
EP0560968B1 (fr) 1996-07-24
DK0560968T3 (da) 1996-11-25
DE69212459D1 (de) 1996-08-29
JPH06503365A (ja) 1994-04-14
AU2762492A (en) 1993-05-03
NO932010L (no) 1993-06-02
FI932491A (fi) 1993-06-01
FI932491A0 (fi) 1993-06-01
HUT69980A (en) 1995-09-28
ATE140626T1 (de) 1996-08-15
WO1993006861A1 (fr) 1993-04-15
EP0560968A1 (en) 1993-09-22
NO932010D0 (no) 1993-06-02
HU219673B (hu) 2001-06-28
ES2090696T3 (es) 1996-10-16
FR2682041A1 (fr) 1993-04-09
US5618541A (en) 1997-04-08
AU662176B2 (en) 1995-08-24
NO306538B1 (no) 1999-11-22
CA2097056A1 (en) 1993-04-04

Similar Documents

Publication Publication Date Title
FI107233B (fi) Menetelmä farmaseuttisen rokotekoostumuksen valmistamiseksi Neisseria meningitidis-infektioita vastaan
DE69630890T2 (de) Peptid-immitierende substanzen in der krebstherapie
FI102248B (fi) Menetelmä rokotteen valmistamiseksi Lymen tautia vastaan
DE69518838T2 (de) Heterodimere trägerzusammensetzung von immunogenen polypeptiden und verfahren zu deren verwendung
JP2010512792A5 (hu)
Patrick et al. Haemophilus influenzae lipopolysaccharide disrupts confluent monolayers of bovine brain endothelial cells via a serum-dependent cytotoxic pathway
JPH10502523A (ja) 変異型ｒドメインを有するジフテリア毒素ワクチン
DE69327553T2 (de) E.Coli P-Fimbriae als immunogener Träger gegen GnRH
Bonnah et al. Biochemical analysis of lactoferrin receptors in the Neisseriaceae: identification of a second bacterial lactoferrin receptor protein
KR101871219B1 (ko) Trail 막투과 펩타이드 유사 돌연변이체, 제조방법 및 응용
FI107262B (fi) Menetelmä rokotekoostumuksen valmistamiseksi Neisseria meningitidis-infektioita vastaan
KR100509712B1 (ko) 나이세리아 락토페린 결합 단백질
CN110156890B (zh) Semaphorin7A单克隆抗体及其在制备用于治疗炎症疾病药物方面的应用
Warren et al. Control of endotoxin activity and interleukin-1 production through regulation of lipopolysaccharide-lipoprotein binding by a macrophage factor
JP2021506330A (ja) 低ｐＨ挿入ペプチド及びその組成物
NZ226025A (en) Plasmodium falciparum merozoite epitope peptides, peptide conjugates, dna and antibodies
CN104096228B (zh) 一种增强流行性嗜血杆菌b型多糖蛋白结合物免疫原性的方法
Corbett et al. Antibodies to outer membrane protein—macromolecular complex (OMP-MC) are bactericidal for serum-resistant gonococci
Griffiths et al. Antigenic relationships of transferrin-binding proteins from Neisseria meningitidis, N. gonorrhoeae and Haemophilus influenzae: Cross-reactivity of antibodies to NH2-terminal peptides
AU6647290A (en) Control of milk secretion
KR20230107810A (ko) Pd-l1의 세포 외 도메인을 포함하는 키메라 항원
US5721342A (en) Control of milk secretion
Maurice et al. A-protein from achromogenic atypical Aeromonas salmonicida: molecular cloning, expression, purification, and characterization
CN104096224A (zh) 一种增强流行性嗜血杆菌b型多糖蛋白结合物免疫原性的方法
Nair et al. The heat-labile and heat-stable enterotoxins of Escherichia coli